Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03484923 |
|---|---|
| Brief Title: | Study of Efficacy and Safety of Novel Spartalizumab Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma (PLATforM) |
| First Submitted : | March 26, 2018 |
| First Submitted that Met QC Criteria : | March 26, 2018 |
| First Posted : | April 2, 2018 |
| Results First Submitted : | December 20, 2023 |
| Results First Posted with QC Comments : | January 17, 2024 |
| Results First Submitted that Met QC Criteria : | January 16, 2024 |
| Results First Posted : | January 18, 2024 |
| Last Update Submitted that Met QC Criteria : | January 16, 2024 |
| Last Update Posted : | January 18, 2024 |